Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Retained Earnings (2016 - 2025)

Historic Retained Earnings for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$290.5 million.

  • InspireMD's Retained Earnings fell 1890.83% to -$290.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$290.5 million, marking a year-over-year decrease of 1890.83%. This contributed to the annual value of -$253.5 million for FY2024, which is 1444.91% down from last year.
  • InspireMD's Retained Earnings amounted to -$290.5 million in Q3 2025, which was down 1890.83% from -$277.8 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Retained Earnings ranged from a high of -$171.4 million in Q1 2021 and a low of -$290.5 million during Q3 2025
  • For the 5-year period, InspireMD's Retained Earnings averaged around -$217.7 million, with its median value being -$210.9 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 739.87% in 2021, then tumbled by 1890.83% in 2025.
  • Over the past 5 years, InspireMD's Retained Earnings (Quarter) stood at -$183.1 million in 2021, then fell by 10.1% to -$201.6 million in 2022, then decreased by 9.88% to -$221.5 million in 2023, then dropped by 14.45% to -$253.5 million in 2024, then decreased by 14.61% to -$290.5 million in 2025.
  • Its Retained Earnings was -$290.5 million in Q3 2025, compared to -$277.8 million in Q2 2025 and -$264.7 million in Q1 2025.